Valbenazine
INGREZZA, INGREZZA Sprinkle
NADAC/unit
$259.0721
No Shortage
Tier 1: 86.9%
PA Req: 416.4%
1 Manufacturers
2 ANDAs
INGREZZA and INGREZZA SPRINKLE are indicated for the treatment of adults with: - tardive dyskinesia [see Clinical Studies ( 14.1 )] . - chorea associated with Huntington’s disease [see Clinical Stu....
vs. brand INGREZZA: Generic saves up to -2491% per unit
Generic Manufacturers
LUPIN LTDNEUROCRINE BIOSCIENCES INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
